To further confirm that the CtBP status modulates tumor sensitivity to platinum treatment in clinical samples, the TCGA OC cohort tumor samples were divided to CtBP high (95 samples) and CtBP low (95 samples) expression groups according to the median expression level of CtBP. The gene discussed is CTBP1; the disease is neoplasm.